5-HT1B/1D receptor drugs for Migraine
16 tracked 5-HT1B/1D receptor drugs in the Migraine race. The class explanation lives on the 5-HT1B/1D receptor page; the full indication pipeline across every mechanism is on the Migraine page.
14 approved / phase 41 Phase 31 US approval withdrawn
Head-to-head evidence: Almotriptan (Axert) vs Eletriptan (Relpax) · Almotriptan (Axert) vs Frovatriptan (Frova) · Almotriptan (Axert) vs Meloxicam/Rizatriptan (Symbravo) · Almotriptan (Axert) vs Naratriptan (Amerge) · Almotriptan (Axert) vs Rizatriptan (Maxalt) · Almotriptan (Axert) vs Rizatriptan (RizaFilm)